SouthernBiotech

Birmingham, United States Founded: 1982 • Age: 44 yrs
Provides antibodies, reagents, and services for scientific research and lab applications.

About SouthernBiotech

SouthernBiotech is a company based in Birmingham (United States) founded in 1982. It operates as a B2B. SouthernBiotech offers products and services including Secondary Antibodies, Primary Antibodies, Reagents and Kits, and Antibody Services. SouthernBiotech operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.

Products & Services of SouthernBiotech

SouthernBiotech offers a comprehensive portfolio of products and services, including Secondary Antibodies, Primary Antibodies, Reagents and Kits, and Antibody Services.

Secondary Antibodies
Research Reagents

Antibodies used for detecting primary antibodies in assays

Primary Antibodies
Research Reagents

Antibodies targeting specific proteins for experiments

Reagents and Kits
Lab Supplies

Tools for applications like flow cytometry and ELISA

Antibody Services
Custom Solutions

Services for antibody production and conjugation

People of SouthernBiotech

6 people are tracked at SouthernBiotech (3 in leadership, 3 in team).

NameRoleGroup
Erica Speegle
Chief Financial OfficerLeadership
Charles Lichtman
CEOLeadership
Jacob Glenn
Director of OperationsLeadership
Leslie Bibb
Technical Services ManagerTeam
Jaclyn Dutton
Production ManagerTeam
April Milton
Monoclonal Research AssistantTeam
Premium access

Complete people profiles for SouthernBiotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of SouthernBiotech

SouthernBiotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
epitomics.com2001Burlingame, United States$16.21M–
Monoclonal antibody technology and products are developed by Epitomics.
ybiologics.com2007Daejeon, South Korea$42.1M–
Developer of antibodies for the treatment of multiple diseases
mabtech.com1986Nacka, Sweden––
Antibodies and immunoassay kits are developed for research applications.
opmbiosciences.com2013Pudong, China$14.42M–
Antibody and vaccine culture media products are developed.
itb-med.com2016Stockholm, Sweden$87M–
Monoclonal antibodies are developed to prevent transplant rejections.
abrevbio.com2018Nanjing, China$90M–
Antibody-drug development platforms are provided for life sciences research.
vectorlabs.com1976Burlingame, United States––
Labeling and detection reagents immunohistochemistry studies and other life science research applications
allelebiotech.com1999San Diego, United States$18M–
Nano-antibodies, iPSCs, fluorescent proteins, and RNAi are developed.
Premium access

Detailed competitors of SouthernBiotech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of SouthernBiotech

Websites that share an audience with SouthernBiotech (southernbiotech.com).

Similar websites

Websites whose visitors overlap most with SouthernBiotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
haemtech.com
100%
––View details
abdserotec.com
99%
––View details
kpl.com
89%
––View details
mitosciences.com
88%
––View details
leinco.com
87%
24.9K#1,218,494View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 17 similar websites and full traffic analytics for SouthernBiotech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 17 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Southernbiotech

Premium access

Complete news archive for SouthernBiotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to SouthernBiotech

10 companies that operate in the same segment as SouthernBiotech (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
2008Ghent, East Flanders, BelgiumUSD 61.9 MUSD 1.41 B355
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M––
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Targeted therapies for cancer treatment are developed.
2005Waltham, Massachusetts, United StatesUSD 198.29 MUSD 172.35 M270
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Plasma-based biologics are developed for immune deficiency and infectious diseases.
2005Ramsey, Minnesota, United StatesUSD 17.55 MUSD 510.17 M685
Antibody drugs for cancer treatment are developed.
2015Singapore, SingaporeUSD 150 M––
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M–520
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
2003United StatesUSD 171.85 MUSD 102.48 M338
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SouthernBiotech

SouthernBiotech was founded in 1982.

SouthernBiotech is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.

SouthernBiotech offers a range of primary and secondary antibodies, immunoreagents, and custom services for research in diagnostics, drug development, and discovery studies. The company produces these products in-house, validates them for quality, and provides services like antibody conjugation and purification. Based in Birmingham, Alabama, USA, it serves researchers and scientists globally through off-the-shelf and customized solutions, ensuring reliable tools for experiments in immunology and related fields.

SouthernBiotech's top competitors include Sino Biological, GenScript and Y-Biologics.

SouthernBiotech offers Secondary Antibodies, Primary Antibodies, Reagents and Kits, and Antibody Services.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available